US 8822218
Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts
granted A61KA61K2035/124A61K2239/48
Quick answer
US patent 8822218 (Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts) held by Stem Cell & Regenerative Medicine International expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Stem Cell & Regenerative Medicine International
- Grant date
- Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2035/124, A61K2239/48, A61K40/15, A61K40/42